Literature DB >> 34591280

Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).

Fumihito Hikage1, Hanae Ichioka1, Megumi Watanabe1, Araya Umetsu1, Hiroshi Ohguro1, Yosuke Ida2.   

Abstract

To study the additive effects of Rho-associated coiled-coil containing protein kinase inhibitors, ripasudil (Rip) to bimatoprost acid (BIM-A) on orbital adipose tissue, three-dimensional (3D) cultures of human orbital fibroblasts (HOFs) were prepared and the physical properties including the 3D spheroid size and stiffness, lipid staining by BODIPY and the mRNA expression of adipogenesis-related genes, PPARγ and AP2, and extracellular matrix (ECM) including collagen (COL)1, 4 and 6, and fibronectin (FN) were analyzed. Adipogenesis (DIF+) induced (1) enlargement and increasing stiffness of the 3D HOFs spheroid, (2) increased lipid staining, the expression of adipogenesis-related gene expressions, and (3) the down-regulation of COL1 and FN and up-regulation of COL4 and COL6. In the presence of BIM-A, (1) such DIF+-induced changes in 3D spheroid size and stiffness were significantly inhibited or enhanced, respectively, (2) the lipid staining and its related gene expressions were significantly down-regulated, and (3) the expression of COL1 and COL6 were up-regulated. By the addition of Rip to BIM-A, the above BIM-A-induced effects were all inhibited, except for the up-regulation of COL6 and FN expression, that is, enlarging and decreasing stiffness, enhancement of lipid staining and its related gene expression, and down-regulation of COL1 expression. Our present study indicates that Rip significantly suppressed BIM-A-induced effects toward 3D HOFs spheroids.
© 2021. Japan Human Cell Society.

Entities:  

Keywords:  Deepening of the upper eyelid sulcus (DUES); Human orbital fibroblasts (HOFs); ROCK; ROCK inhibitor; Rho-kinase; Three-dimensional (3D) tissue culture

Mesh:

Substances:

Year:  2021        PMID: 34591280     DOI: 10.1007/s13577-021-00623-y

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  42 in total

1.  Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats.

Authors:  Johanne Bertrand; Matthew J Winton; Nieves Rodriguez-Hernandez; Robert B Campenot; Lisa McKerracher
Journal:  J Neurosci       Date:  2005-02-02       Impact factor: 6.167

2.  The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration.

Authors:  Karolien Hollanders; Tine Van Bergen; Nele Kindt; Karolien Castermans; Dirk Leysen; Evelien Vandewalle; Lieve Moons; Ingeborg Stalmans
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-27       Impact factor: 4.799

3.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

4.  Rho kinase proteins regulate global miRNA expression in endothelial cells.

Authors:  Jessica M Stiles; Vittal Kurisetty; Dianne C Mitchell; Brad A Bryan
Journal:  Cancer Genomics Proteomics       Date:  2013 Nov-Dec       Impact factor: 4.069

5.  Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.

Authors:  Hiroshi Watabe; Sanae Abe; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2011-06-11       Impact factor: 2.447

6.  The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction.

Authors:  Naoki Okumura; Noriko Koizumi; Morio Ueno; Yuji Sakamoto; Hiroaki Takahashi; Junji Hamuro; Shigeru Kinoshita
Journal:  Cornea       Date:  2011-10       Impact factor: 2.651

7.  Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.

Authors:  Hai-Bo Tan; Yi-Sheng Zhong; Yu Cheng; Xi Shen
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

8.  Involvement of phosphorylation of myosin phosphatase by ROCK in trabecular meshwork and ciliary muscle contraction.

Authors:  C Fukiage; K Mizutani; Y Kawamoto; M Azuma; T R Shearer
Journal:  Biochem Biophys Res Commun       Date:  2001-10-26       Impact factor: 3.575

9.  Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.

Authors:  Tamotsu Yokota; Kazunori Utsunomiya; Kanta Taniguchi; Atsushi Gojo; Hideaki Kurata; Naoko Tajima
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

10.  Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.

Authors:  Ryoichi Arita; Yasuaki Hata; Shintaro Nakao; Takeshi Kita; Muneki Miura; Shuhei Kawahara; Souska Zandi; Lama Almulki; Faryan Tayyari; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

View more
  1 in total

1.  Brimonidine Modulates the ROCK1 Signaling Effects on Adipogenic Differentiation in 2D and 3D 3T3-L1 Cells.

Authors:  Araya Umetsu; Yosuke Ida; Tatsuya Sato; Megumi Watanabe; Yuri Tsugeno; Masato Furuhashi; Fumihito Hikage; Hiroshi Ohguro
Journal:  Bioengineering (Basel)       Date:  2022-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.